PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
21.05.24
/
50%
€35.00
Target price
21.05.25
€29.48
Performance (%)
14.86%
End price
22.05.25
€40.20
Summary
This prediction ended on 22.05.25 with a price of €40.20. The prediction closed with a disappointing performance of 14.86%. The_Goldman_Sachs_Gr has a follow-up prediction for PTC Therapeutics Inc. where he still thinks PTC Therapeutics Inc. is a Sell. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | 3.451% | 3.451% | 60.000% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
Stopped prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.00
04.12.24
04.12.24
€40.03
04.12.25
04.12.25
39.36%
05.12.25
05.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.60
28.05.24
28.05.24
€29.42
28.05.25
28.05.25
25.60%
29.05.25
29.05.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€20.61
18.09.24
18.09.24
40.35%
19.09.24
19.09.24